LIVE MARKET TRACKER :   BSE SENSEX   32389.96      |    NSE NIFTY 10146.55    
GLOBAL MARKETS :  NASDAQ 6586.9258   -0.5630%    |    FSI London 7523.77   -0.25%    |    NIKKEI Japan 21448.52   +0.40%
  USD GBP EUR CAD AUD INR
USD - 0.7575 0.8442 1.2462 1.2691 65.0490
GBP 1.3203 - 1.1144 1.6452 1.6753 85.7903
EUR 1.1849 0.8975 - 1.4765 1.5035 77.0144
CAD 0.8027 0.6081 0.6771 - 1.0188 52.1410
AUD 0.7881 0.5971 0.6653 0.9821 - 51.1810
INR 0.0154 0.0117 0.0130 0.0192 0.0196 -
Indian-Commodity  :  Corporate  :  Maruti Suzuki's - WagonR scales unique feat of cumulative two-million sales

Maruti Suzuki's - WagonR scales unique feat of cumulative two-million sales (26-Sep-2017)

Maruti Suzuki's popular car, WagonR has scaled the unique feat of two-million sales in cumulative wholesales. Launched in 1999, WagonR continues to feature among the top five best selling cars in the country for the last over 10 years.

WagonR scored its first million sales in 2011, nearly 133 months after its launch. However, with gaining mass popularity and increasing mobility in the country, WagonR scaled its next million sales mark in just 79 months. This is the testimony of WagonR being relevant and delighting customers.

Maruti Suzuki has consistently introduced new design as well technology upgrades in WagonR, which has made it as top choice for buyers. The Company has kept in mind that customers are aspirational and expects enhanced quality of design, features and technologies in their car.

Maruti Suzuki India (formerly known as Maruti Udyog) is an automobile manufacturer in India. It provides passenger cars, utility vehicles and vans. The firm also offers pre-owned car sales, fleet management and car financing services.


Top News Today
Suven Life Sciences secures product patent in Singapore
(18-Oct-2017)

Suven Life Sciences secures product patent in SingaporeSuven Life Sciences has secured one product patent from Singapore corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents......click on news to read complete article.

Jubilant Life Sciences issues commercial papers worth Rs 50 crore
(18-Oct-2017)

Jubilant Life Sciences issues commercial papers worth Rs 50 croreJubilant Life Sciences has issued Commercial Papers (CPs) aggregating to Rs 50 crore on October 17, 2017. The company has issued two commercial papers of Rs 25 crore each providing an interest rate of......click on news to read complete article.

Peninsula Land receives Rs 200 crore from Godrej Skyline for Pune land
(18-Oct-2017)

Peninsula Land receives Rs 200 crore from Godrej Skyline for Pune landPeninsula Land has received Rs 200 crore out of the total consideration of Rs 226 crore from Godrej Skyline Developers for sale of property situated at Village Mamurdi, Taluka Haveli, District - Pune,......click on news to read complete article.

International Stock News
Asian markets trade mostly lower in early deals on Wednesday
(18-Oct-2017)

Asian markets trade mostly lower in early deals on WednesdayMost of the Asian equity benchmarks are trading lower in the early deals on Wednesday with investors trading cautiously as China's President Xi Jinping spoke at the beginning of the Communist Party's 19th......click on news to read complete article.

US markets closed mostly higher on round of positive earnings report
(18-Oct-2017)

US markets closed mostly higher on round of positive earnings reportThe US markets closed mostly higher on Tuesday, with both the Dow and the S&P 500 finishing at records as a round of positive earnings report from major companies boosted positive sentiment and......click on news to read complete article.

Asian markets trade mostly higher in early deals on Tuesday
(17-Oct-2017)

Asian markets trade mostly higher in early deals on TuesdayMost of the Asian equity benchmarks are trading in green in the early deals on Tuesday, with the fresh record highs on Wall Street and firm commodity prices boosting investors' sentiments. Comments by......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.